Inventor
MAHENDRA R. PATEL
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering14%
B28BShaping clay or other ceramic compositions10%
B29CShaping or joining of plastics10%
B29KIndexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials or to materials for moulds, reinforcements, fillers or preformed parts, e.g. inserts10%
B30BPresses in general10%
Y02PClimate change mitigation technologies in the production or processing of goods10%
A61JContainers specially adapted for medical or pharmaceutical purposes5%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations5%
B01LChemical or physical laboratory apparatus for general use5%
PatentTitleYear
12,202,196Three-dimensional printing system and equipment assembly202511,826,466Bendamustine solution formulations202311,732,964Lyophilization promoting element202311,383,440Three-dimensional printing system and equipment assembly202211,278,501Method and system for forming a dosage form within a packaging2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to Aprecia Pharmaceuticals LLC (3)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to NAVINTA III INC (1)· patent assignee history
2023Patents assigned to NAVINTA LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Aprecia Pharmaceuticals LLC | 3 | 2022–2025 |
| NAVINTA III INC | 1 | 2023 |
| NAVINTA LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |